Open an account

CTT Pharmaceutical Holdings

CTTH · OTC

$0.0589−$0.0079 (−11.83%)TodayMarket closed ·
No price history for this range.

About CTTH

CTT Pharmaceutical Holdings, Inc. engages in the development of drug delivery systems technology within the pharmaceutical industry. The company is headquartered in Tampa, Florida. Its technology platform includes the development of advanced oral delivery thin wafers to deliver treatment as an alternate to smoking and ingestion. The wafer is an orally administrable paper-thin polymer film used as a carrier for pharmaceutical agents. The company rapidly dissolves to release the pharmaceutical agent as soon as it comes in contact with saliva, thus obviating the need for water during administration. Its oral film technology drug delivery system can be provided in various packaging configurations, ranging from unit-dose pouches to multiple-dose blister packages. Its drug delivery system technology includes nicotine, vitamins, pharmaceuticals, and many other actives. The company offers oral thin strips for pain management and inflammation indications, such as arthritis. VetWafe is used for pain management for pet markets. The company is a thin film for treating dogs and cats.

Employees
0
Headquarters
Tampa, Florida
Listed
Apr 18, 1997
Sector
Health Care
Industry
Pharmaceuticals
Website
cttpharmaceuticals.com

CTTH key statistics

Market cap
3.52M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
25.68K
Volume
3
Open price
$0.0526
High today
$0.0589
Low today
$0.0526
52 Week high
$0.10
52 Week low
$0.035

CTT Pharmaceutical Holdings (CTTH) at a glance

CTT Pharmaceutical Holdings (CTTH) last traded at $0.0589, with a market cap of 3.52M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.0526 and $0.0589. The current price is 12.0% above the day's low and 0.0% below its high.

Volume so far is 3 shares, below the average of 25.68K shares a day.

Over the past year CTT Pharmaceutical Holdings has ranged from $0.035 to $0.10, and now sits 37% of the way up that range.

CTTH news

  • Press releaseACCESS Newswire

    CTT Pharma Uplists to the OTCQB Today

  • Press releaseACCESS Newswire

    CTT Pharmaceuticals Holdings, Inc. Announces Uplisting to OTCQB Market Trading

  • Press releaseACCESS Newswire

    CTT Pharma Gives Uplisting Update

  • Press releaseACCESS Newswire

    CTT Pharma Gives Update On NSF Grant

  • Press releaseACCESS Newswire

    Retransmission: CTT Pharma and Johns Hopkins University Submits Proposal for $15 Million NIH Grant for Smoking Cessation

Similar companies

Companies in the same industry as CTT Pharmaceutical Holdings

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.